IDC demonstrates outstanding success rate for product developments
Working in the product innovation industry - where the failure rate of new products can be disproportionately high - product design company, IDC, is delighted to report that following a recent audit, 91% of IDC's development work was on products that have gone on to be commercially successful.
Robotics-based competition inspires young minds
The University of Cambridge Department of Engineering recently played host to a space-themed robot games tournament, designed to spark children’s interest in real world issues and develop their technology skills.
Just another article... or the triumph of a thrilling title
Want to drum up some interest in that talk you're giving, or your new product, or service? Put some hard work into a striking title, advises Communications Consultant Simon Hall (but don't stoop to the lows of Do Woodpeckers get Headaches?)
Microsoft recognises Business Cloud Integration as SharePoint Business Applications Partner
Business Cloud Integration is thrilled to be named by Microsoft as a Charter Member of the SharePoint Business Applications Partner Program. Business Cloud Integration is one of a select number of Partner Program members worldwide, and one of only five Charter Members in the UK.
Cambridge spin-out company wins £18m to fight Alzheimer's
Wren Therapeutics secures £18 million in funding to tackle protein misfolding diseases.
Sookio Labs: Using stories on social media
So many social media platforms now use a stories feature. Platforms like Facebook, Instagram, Snapchat and LinkedIn now all have stories. But how do they compare?
Could temping help you to achieve your New Year career resolutions?
Have you decided that 2019 is the year to make a career change? Or simply to change the way in which you work? Professional recruitment specialists Pure explain how becoming a temp could open up doors into a new industry, help you to discover what you would really like to do or provide you with the variety, flexibility and work-life balance you are looking to achieve.
The Growth Corridor – vision and realities
The “Oxford-Cambridge Growth Corridor” is now becoming highly topical among the professional, political and business communities within its region. David Wells of Hewitsons discusses the issues.
Stingray gig provides 'Something to look forward to'
A special charity gig takes place on Saturday 16th March at the Blue Moon, Cambridge, featuring local indie/rock band 'Stingray'- who have kindly donated their talent for the night. The event is in aid of local Cambridge-based charity 'Something to look forward to' which supports people and their familes who are coming to terms with a terminal cancer diagnosis.
Babel Cultural Newsletter: Australia
Australia Day is the official national day of Australia, celebrated annually on 26 January. An English-speaking nation, Australia may seem familiar to expats from Europe and the US, but there are some cultural differences to be aware of. Read Babel's newsletter to find out more and don't forget to enter the quiz!
Making liposomal formulations for the delivery of RNA vaccines
A Dolomite Microfluidics’ set-up for high throughput single cell encapsulation is helping researchers at the Department of Medicine at Imperial College, London, to develop novel liposomal formulations for RNA vaccines targeting diseases such as HIV, influenza, rabies and chlamydia
ZEISS introduces next generation X-ray microscopes
ZEISS introduces two new advanced models of the ZEISS Xradia Versa family: The ZEISS Xradia 610 & 620 Versa X-ray microscopes excel through faster non-destructive imaging of intact samples without sacrificing resolution and contrast over the full range of power and kV.
nCipher Security delivers trust, integrity and control to business critical information
Newly formed organization preserves competition and ensures continued innovation in general purpose HSM market
o2h Ventures launches £10m Therapeutics Fund
Leading national law firm Mills & Reeve has acted for o2h Ventures Limited in the creation of its Therapeutics Fund with a target size of £10m, set up to invest in early-stage biotech therapeutics and related AI opportunities.
Genetic study reveals possible new routes to treating osteoarthritis
In the largest genetic study of osteoarthritis to date, scientists have uncovered 52 new genetic changes linked to the disease, which doubles the number of genetic regions associated with the disabling condition.
New era for UK superbug research: 20 year vision and five year action plan
The UK’s new 20 year vision and five year National Action Plan (2019-2024) for containing, controlling and mitigating antimicrobial resistance has been announced by Health Secretary Matt Hancock at the World Economic Forum at Davos today.
Say hello to the East’s first Nursing Associates
The East of England’s first Nursing Associates – a new role within the NHS to address the growing demands on the UK’s nursing workforce – have celebrated completing their course at Anglia Ruskin University in Cambridge.
Virtual reality in research
Computational scientist Stephen Taylor and his team at the MRC Weatherall Institute of Molecular Medicine (MRC WIMM) are helping scientists and surgeons explore biological structures up closer than ever before.
Arecor featured by the highly regarded industry publication, Scrip
Arecor Limited, the specialty pharmaceutical company leveraging its innovative and proprietary formulation technology to develop superior treatments for a range of disease areas, including diabetes, is pleased to announce that a feature profile by the highly regarded industry publication, SCRIP, is now available for viewing.
GHX shortlisted for HSJ Healthcare Partnership Awards 2019
Global Healthcare Exchange (GHX), a leader in cloud-based healthcare supply chain management solutions, which helps empower healthcare organisations to enable better patient care and maximise industry savings, has been shortlisted twice at Health Service Journal’s (HSJ's) Healthcare Partnership Awards 2019.
Cambridge MP cautiously welcomes release of bus review
Daniel Zeichner, MP for Cambridge, has welcomed the release of the Cambridge and Peterborough Combined Authority (CPCA) Strategic Bus Review report, which was commissioned by the Combined Authority early last year. He says that it is a very small, slow step in the right direction and is critical of the lack of evidence underpinning the report.
Heart disease risk begins in the womb, study in sheep suggests
Offspring whose mothers had a complicated pregnancy may be at greater risk of heart disease in later life, according to a new study in sheep. The research, led by a team at the University of Cambridge, suggests that our cards may be marked even before we are born.
Study investigates links between hospital IT and reputation
A new study co-authored by Stavros Polykarpou and Michael Barrett of Cambridge Judge Business School focuses on the ongoing and potentially fickle relationship between hospital IT investment and the hospital’s reputation.
Lucy Frazer MP officially opens newly expanded GW Pharmaceuticals' global Head Office: Histon
GW Pharmaceuticals is delighted to announced that Lucy Frazer QC MP (Conservative, South East Cambridgeshire) has officially opened its expanded global Head Office in Histon.
Ian Dunham appointed as Open Targets Director
Open Targets has appointed Ian Dunham as its new Director. Dunham will focus on the delivery of Open Targets’ established research programme to exploit advances in genetics and genomics for drug target identification and prioritisation. He also aims to increase the use of new approaches to the programme, including single-cell sequencing, CRISPR and artificial intelligence.